Chronic Graft-Versus-Host Disease and Disease Status at Relapse as Predictors of Clinical Outcomes in Patients Receiving Azacitidine & Donor Lymphocyte Infusions as Salvage Therapy for Post Allograft Relapse of Myeloid Neoplasms
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.221
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
Elsevier BV